EUA
Bio-Rad SARS-CoV-2 ddPCR Test
FDA Emergency Use Authorization · Bio-Rad Laboratories, Inc · Mar 15, 2022
Key facts
| Product | Bio-Rad SARS-CoV-2 ddPCR Test |
|---|---|
| Company | Bio-Rad Laboratories, Inc |
| Product type | RT-droplet PCR, Multiple Targets |
| Date | Mar 15, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: